Updated dental guidance on anticoagulants and antiplatelet drugs

  • Date: 30 March 2022

UPDATED guidance on the management of dental patients taking anticoagulants or antiplatelet drugs has been published by the Scottish Dental Clinical Effectiveness Programme (SDCEP).

The guidance aims to provide clear and practical recommendations and advice to enable the dental team to manage and treat this patient group, and covers assessment of bleeding risk, treatment planning and management of dental patients taking the various types of medication.

It is aimed primarily at members of the dental profession but also has relevance for medical and pharmacy professionals who prescribe and dispense anticoagulants or antiplatelet drugs.

The guidance has been updated following a thorough review of the evidence and consultation with dental organisations, including the College of General Dentistry. Most of the recommendations remain unchanged from the original 2015 edition but changes include the addition of advice on the direct oral anticoagulant Edoxaban, and on patients taking low molecular weight heparin.

The full version of the guidance together with a summary ‘Quick Reference Guide’ and information for patients can be accessed via the SDCEP website.

This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.

Save this article

Save this article to a list of favourite articles which members can access in their account.

Save to library

Related Content

Equality, diversity and inclusion workshop

Equality, diversity and inclusion workshop


CQC update: Single Assessment Framework (Dental)

For registration, or any login issues, please visit our login page.